8-K: Planet 13 Announces Q4 2023 Financial Results with Revenue of $23.0 Million and Positive Adjusted EBITDA

Planet 13 reported a Q4 2023 revenue of $23.0 million and a net loss of $14.3 million, which included a non-cash impairment loss of $7.2 million, while achieving positive adjusted EBITDA of $1.3 million.

Summary

• Planet 13 announced its financial results for the three-month and twelve-month periods ended December 31, 2023.
• Q4 2023 revenue was $23.0 million, a decrease of 7.5% compared to the same period in 2022.
• The company reported a net loss of $14.3 million for Q4 2023, which included a non-cash impairment loss of $7.2 million.
• Adjusted EBITDA for Q4 2023 was $1.3 million, compared to an adjusted EBITDA loss of $0.6 million in the same period of 2022.
• Full year 2023 revenue was $98.5 million, a decrease of 5.8% compared to 2022.
• The full year net loss was $73.6 million, which included a one-time, non-cash $46.8 million impairment.
• Adjusted EBITDA for the full year 2023 was $1.4 million, compared to an adjusted EBITDA loss of $7.5 million in 2022.
• The company's cash balance decreased to $17.3 million from $38.8 million year-over-year.
• Total assets decreased to $151.7 million from $220.1 million year-over-year.

Sentiment

Score: 7

Explanation: The document shows a mixed picture with revenue declines but significant improvements in profitability and strategic positioning. The positive adjusted EBITDA and cost control measures are encouraging, but the net loss and cash burn are concerning. The strategic moves in Florida are a positive sign for future growth.

Positives

• The company achieved positive adjusted EBITDA in both Q4 2023 and for the full year 2023.
• Gross profit margin improved in Q4 2023 due to reduced product discounting.
• Operating expenses were significantly reduced in Q4 2023.
• The company has taken steps to strengthen its balance sheet through the acquisition of VidaCann.
• Planet 13 is well-positioned to benefit from potential adult-use cannabis legalization in Florida.
• The company has expanded its leadership team and board.

Negatives

• Q4 2023 revenue decreased by 7.5% compared to the same period in 2022.
• Full year 2023 revenue decreased by 5.8% compared to 2022.
• The company reported a net loss of $14.3 million in Q4 2023 and $73.6 million for the full year 2023.
• The net loss for the full year 2023 was impacted by a one-time, non-cash impairment charge of $46.8 million.
• The company's cash balance decreased significantly year-over-year.

Risks

• The company faces ongoing pressure on cannabis prices.
• Economic uncertainties may impact future performance.
• The company experienced a decline in revenue at the SuperStore and in wholesale revenue in Nevada.
• The company's financial results are subject to risks and uncertainties discussed in their annual report.

Future Outlook

The company is positioned for growth through the acquisition of VidaCann and is looking to capitalize on the potential for adult-use cannabis in Florida.

Management Comments

• Larry Scheffler, Co-CEO, stated that the company's performance was highlighted by solid revenue and positive Adjusted EBITDA, fueled by the expansion of gross margins and effective cost management.
• Bob Groesbeck, Co-CEO, commented that the company has taken decisive actions to fortify its balance sheet and is set up for growth through the acquisition of VidaCann.

Industry Context

The cannabis industry is facing economic uncertainties and pressure on prices, but Planet 13 is aiming to leverage its brand and strategic acquisitions to navigate these challenges and capitalize on new market opportunities, such as the potential for adult-use in Florida.

Comparison to Industry Standards

• While Planet 13's revenue declined year-over-year, the improvement in adjusted EBITDA and gross margin suggests a focus on profitability, which is a key concern for many cannabis companies.
• Compared to companies like Curaleaf and Trulieve, which have a larger national footprint, Planet 13 is more concentrated in specific markets like Nevada and Illinois, but is expanding into Florida.
• The company's focus on a unique retail experience with its SuperStore in Las Vegas differentiates it from standard dispensaries, similar to how companies like MedMen have tried to create a premium retail experience, though MedMen has faced significant financial challenges.
• The impairment charges taken by Planet 13 are not uncommon in the cannabis industry, as companies adjust to market conditions and re-evaluate asset values, similar to what other cannabis companies have experienced.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the revenue decline and net loss, but encouraged by the improved profitability and strategic moves.
• Employees may be impacted by the company's cost control measures.
• Customers may benefit from the company's focus on improving the retail experience and product offerings.
• Suppliers may be impacted by the company's efforts to manage costs.

Next Steps

• The company will continue to focus on expanding its operations in existing markets.
• Planet 13 will work to capitalize on the potential for adult-use cannabis in Florida.
• The company will continue to manage costs and improve profitability.
• The company will continue to develop its brand and product offerings.

Key Dates

Keywords

cannabis, financial results, EBITDA, revenue, net loss, dispensary, retail, Nevada, Florida, impairment, gross margin, operating expenses